Skip to main content
Retour
GENB logo

Generate Biomedicines, Inc.

Qualité des données : 100%
GENB
NASDAQ Financial Services Asset Management
12,03 €
▼ 0,49 € (-3,91%)
Cap. Boursière : 1,53B
Fourchette du Jour
11,94 € 12,83 €
Fourchette 52 Semaines
11,00 € 15,32 €
Volume
428 154
Moyenne 50J / 200J
12,26 € / 12,26 €
Clôture Précédente
12,52 €

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Financial Services (854 pairs)

Métrique Action Médiane du Secteur
P/E -7,6 10,3
P/B 1,1
ROE % 11,6
Net Margin % -637,0 16,8
Rev Growth 5Y % 11,6
D/E 0,5

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Aucune estimation prévisionnelle disponible

Points Clés

Negative free cash flow of -204,13M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)55,89%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net Margin-636,99%
Op. Margin-737,04%

Sécurité

Debt / Equity
N/A
Current Ratio2,85
Interest Coverage-206,92

Valorisation

P/E Ratio
-7,55
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 55,89% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 31,89M Net Income (TTM) -203,15M
ROE N/A ROA -61,53%
Gross Margin 100,00% Operating Margin -737,04%
Net Margin -636,99% Free Cash Flow (TTM) -204,13M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 2,85
Interest Coverage -206,92 Dividend Yield 0,00%
Valuation
P/E Ratio -7,55 P/B Ratio N/A
P/S Ratio 48,07 PEG Ratio -0,02
EV/EBITDA N/A Dividend Yield 0,00%
Market Cap 1,53B Enterprise Value 1,48B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024
Revenue 31,89M 20,46M
Net Income -203,15M -173,77M
EPS (Diluted) -4,98 -1,68
Gross Profit 31,89M 20,46M
Operating Income -235,07M -196,94M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024
Total Assets 330,18M 518,26M
Total Liabilities 953,38M 953,35M
Shareholders' Equity -615,97M -434,52M
Total Debt 68,53M 76,97M
Cash & Equivalents 121,65M 176,27M
Current Assets 234,37M 407,49M
Current Liabilities 82,20M 86,63M